Phase 3 EMBARK Study Confirms XTANDI Plus Leuprolide Improves Overall Survival in Non-Metastatic Prostate Cancer
Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the…
Cleveland Clinic Abu Dhabi introduces Focal One High-Intensity Focused Ultrasound for prostate cancer
Abu Dhabi, UAE- February 14, 2024: Cleveland Clinic Abu Dhabi, part of…